Use of RR/SR-ractopamine

Details for Australian Patent Application No. 2008331928 (hide)

Owner Bridge Pharma, Inc.

Inventors Gogritchiani, Eliso; Meier, Viktor; Aberg, A. K. Gunnar; Reuter, Karl; Stolz, Florian

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008331928

PCT Pub. Number WO2009/073051

Priority 61/005,688 08.12.07 US; 61/005,214 03.12.07 US

Filing date 6 August 2008

Wipo publication date 11 June 2009

Acceptance publication date 16 August 2012

International Classifications

A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/073051 Priority application(s): WO2009/073051

16 August 2012 Application Accepted

  Published as AU-B-2008331928

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331929-Method and system for inflight refueling of unmanned aerial vehicles

2008331920-Tryptamine sulfonamides as 5-HT6 antagonists